That was the whole point of this global clinical trial.
They’ll kill most the aids patients and cancer patients in the process as had always happened.
Cancer cells have multiple pathways, when one gets blocked some of those cells die and the ones that survive find a new pathway. It’s no different then bacteria and antibiotics eventually you get antibiotic resistance but with cancer it happens much quicker.
There was a company coming out with “the hundred most common cancer peptides” that cancers cells use and targeting all 100 and had amazing results so far, it can even be used preventatively. They can also add in more as needed if the cancer cells escape those 100.
Hopefully this novel and effective approach isn’t sidelined.
Like monochilonal antibody treatment it'll be given to the elite first then rationed to the undesirables.
(post is archived)